Inverness Medical Innovations Inc.

Alere Inc. (NYSE:ALR), formerly Inverness Medical Innovations, said it is increasing its debt offering by another $50 million, bringing the total up to $400 million in notes offered to foreign institutional investors.

The Waltham, Mass.-based personal health firm previously said it would issue some $350 million in convertible debt as senior subordinated notes via a private placement under regulatory rules that don’t require the securities to be registered. Under Regulation S of the Securities Act, the notes can’t be sold in the U.S. unless they’re registered with the federal Securities & Exchange Commission.

Inverness Medical Innovations, Inc. (NYSE:IMA) gave itself a makeover at a July 14 shareholder meeting.

Company stockholders approved the company’s name change to Alere Inc. (NYSE:ALR).

The Waltham, Mass.-based diagnostics firm created the brand Alere in 2008 after acquiring Alere Medical, ParadigmHealth and Matria Healthcare and merging them under a single umbrella. The company said it expects its NYSE stock symbol to change from IMA to ALR July 19.

With about $2 million in unregistered bonds still in the hands of investors, despite a pair of deadlines already gone by the boards, Inverness Medical Innovations Inc. (NYSE:IMA) added another week for stragglers to exchange those notes for new, registered versions of the debt securities.

The new notes pay the same 7.875 percent annual yield and will mature in February 2016, just like the originals, but will allow the noteholders to sell them to other investors just like any other registered bond in the credit markets.

Inverness Medical Innovations Inc. (NYSE:IMA) is giving a handful of stragglers a little extra time to cash in their unregistered bonds.

The Waltham, Mass.-based diagnosis, monitoring and health management firm is extending until June 4 the tender period for note-holders to turn in Inverness bonds maturing in February 2016. The tender period had been set to expire at 5 p.m May 24, with about 98 percent of the note-holders making that deadline.

Inverness Medical Innovations Inc. (NYSE:IMA) is giving one of its subsidiaries a big promotion.

The Waltham, Mass.-based diagnostics firm is planning a makeover by changing its name to Alere, a brand it created in 2008 after acquiring Alere Medical, ParadigmHealth and Matria Healthcare and merging them under a single umbrella.